BioSpace News Archive

Benchling selected for meeting criteria and providing demonstrated market fit for AWS customers

The Privately-Owned ER Alternative is Staffed by ER Doctors and Offers Patients More Medical Services Than Most Urgent Care Centers

Health Canada would like to remind Canadians of the risks posed by unauthorized health products and to reaffirm that it will not hesitate to take action against illegal manufacturing and distribution of health products that could pose a health and safety risk to Canadians.

Dr. John DeGroot, Dr. Hope Rugo and Dr. Javier Cortés Join Medical Oncology Advisory Board

Acceleron Pharma Inc., a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced that it has been included in the recently released Institutional Investor 2020 “All-America Executive Team” rankings as one of the country’s “Most Honored” companies.

Voclosporin achieved statistically superior Renal Response rate (p < 0.001) and comparable safety profile versus standard of care

Omeros Corporation announced that it has commenced a registered underwritten public offering of its common stock.

Awards presented during cocktail reception sponsored by Ambra Health at the annual RSNA conference.

The aggregate net proceeds from the note are approximately $1.94 million, after deducting the initial purchaser’s discount, commissions and estimated offering expenses.

To obtain real-world data on the use of RADICAVA, MTPA engaged Soleo Health, a provider of home and alternative-site infusions and specialty pharmacy services in the U.S., to share information from 163 patients receiving RADICAVA for at least three months